Biography

• DeirdreGillespie
  Deirdre Y. Gillespie, M.D.
  

  Director
  
  Deirdre Y. Gillespie, M.D. has been a director since June 2010. She has served as a member of our Audit and Corporate Governance/Nominating Committees since June 2010. She is the former President and Chief Executive Officer of publicly-held La Jolla Pharmaceutical Company. She has over 20 years experience in general management in pharmaceutical and biotechnology companies.
  
  Prior to joining La Jolla Pharmaceutical Company, Dr. Gillespie served from 2001 to 2005 as President and Chief Executive Officer of Oxxon Therapeutics, Inc., a privately held pharmaceutical company spun out of Oxford University and ultimately acquired by Oxford Biomedica Plc. Before that, Dr. Gillespie was Chief Operating Officer of Vical, Inc., a publicly-traded gene delivery company, from 2000 to 2001, and Executive Vice President and Chief Business Officer of the company. During her career, Dr. Gillespie also held a number of senior strategic and commercial positions at DuPont Merck Pharmaceutical Company, from 1990 to 1996, including Vice President of Marketing, and at Sandoz Pharma AG (Novartis), in clinical development, from 1986 to 1990. Prior to that time, she spent five years in internal medicine in London and Oxford. Dr. Gillespie received her M.B.A. from the London Business School and her M.D. and B.Sc. from London University.